Business Wire · May 2026
Extends the same starting price to eligible Ozempic prescriptions for out-of-pocket Canadian patients.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Phoenix Digital Health Inc. is a Toronto-based Canadian telehealth clinic for men, offering provider-reviewed online care and discreet prescription delivery for conditions such as erectile dysfunction, hair loss, weight management, testosterone support, early climax, skincare, smoking cessation, and at-home blood testing via Phoenix Labs.
Primary product
Canadian men's telehealth clinic with provider-reviewed prescriptions and discreet delivery
Founded
2019
Headquarters
200 Wellington St W, Suite 1400, Toronto, Ontario M5V 3C7, Canada
Team size
51-200
Work style
Onsite
Industry
Wellness and Fitness Services
Sub-industry
Digital health / telehealth for men's health
7 jobs at Phoenix
Offices
Business model
Stage
Series A
Latest round
Series A · Mar 2025
Latest amount
$34.9M
Mar 2025 · Valspring Capital
Jan 2025 · CIBC Innovation Banking
Jan 2023
May 2021
Mar 2021 · Y Combinator
Leadership
Founder & Co-CEO
Founder & Co-CEO
Medical Director
Chief of Staff / Executive Director, Strategic Initiatives
VP of Product
Head of Brand
Head of User Experience
Investors
Mission-driven and patient-centric, with strong in-person collaboration in Toronto and a notable emphasis on AI in engineering and operations.
Work style
Onsite
Compensation
A senior full-stack engineering role publicly posted at CA$125k–CA$155k, with benefits including healthcare coverage, wellbeing allowance, and flexible time off. No broader company-wide compensation policy is public.
Benefits
Pricing
Free online assessment with treatment pricing bundled into medication pricing and/or subscription plans; public examples include sildenafil starting at $54.47 and Ozempic/generic semaglutide starting at $124.99 per month.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately USD 35M–36M ARR (public estimates vary)
Estimated monthly visits
229K
Traffic estimate as of Jul 2026
Business Wire · May 2026
Extends the same starting price to eligible Ozempic prescriptions for out-of-pocket Canadian patients.
Business Wire · May 2026
Launches direct-to-patient generic semaglutide in Canada at a starting price of $124.99, following Health Canada approval.
Business Wire · Dec 2025
Shares survey findings on Canadians' health information-seeking behavior, weight loss priorities, and attitudes toward AI-assisted treatment recommendations.
Business Wire · Mar 2025
Announces a CAD 50 million Series A led by Valspring Capital, with renewed Y Combinator participation and support from CIBC Innovation Banking.
BetaKit · Mar 2025
Explains Phoenix's capital raise, team growth plans, board changes, revenue growth commentary, and Canadian market positioning.